Immedica publishes Business Review and Annual & Sustainability report 2022
Stockholm, April 26 , 2023 - Immedica has today published its Business review and Annual & Sustainability report 2022. This is the first report for Immedica in this format. Immedica is a young and still relatively small company, but our ambitions are nothing but high. “At Immedica, we believe we have an important role to fill in society in bringing new innovative treatments to patients with rare diseases for whom there are currently no viable treatment options.”comments Anders Edvell CEO. The integrated report is attached to his announcement. About Immedica Pharma